Thrombophilia testing in the era of direct oral anticoagulants
Jennifer Darlow and Holly Mould
DOI: https://doi.org/10.7861/clinmed.2020-1008
Clin Med September 2021 Jennifer Darlow
AManchester Royal Infirmary, Manchester, UK
*equal first authors
Roles: haematology registrar
Holly Mould
BUniversity of Manchester, Manchester, UK
*equal first authors
Roles: medical student
Article Information
vol. 21 no. 5 e487-e491
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online September 10, 2021.
Article Versions
- Latest version (September 7, 2021 - 08:00).
- You are viewing the most recent version of this article.
Copyright & Usage:
© Royal College of Physicians 2021. All rights reserved.
Author Information
Article usage
Article Tools
Thrombophilia testing in the era of direct oral anticoagulants
Jennifer Darlow, Holly Mould
Clinical Medicine Sep 2021, 21 (5) e487-e491; DOI: 10.7861/clinmed.2020-1008
Citation Manager Formats
Jump to section
- Article
- ABSTRACT
- Introduction
- Types of thrombophilia
- Who needs thrombophilia testing?
- Heritable thrombophilias
- Risk scores
- Acquired thrombophilias
- How do DOACs affect thrombophilia testing?
- DOAC effects on APS testing
- Possible solutions to the DOAC effect on thrombophilia testing
- The DOAC-StopTM
- Can we give DOACs in thrombophilia?
- Can we give DOACs in APS?
- Conclusion
- Key practice implications
- Acknowledgements
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.